GLP-1 receptor agonist use and weight change in patients with breast cancer
For example, in a clinical trial for Wegovy, 4% of adults who have type 2 diabetes and a BMI over 27 (considered overweight) developed diabetic retinopathy, a potential complication of diabetes that leads to blood vessel damage in the retina
The obesity medicine field has gained a new entrant, with AbbVie on Monday announcing it had licensed an experimental weight loss drug from a Danish company that is in a Phase 1 trial
Table 1 summarizes patient characteristics, treatment details and weight loss outcomes, while Figure 1 shows the trajectory of the patients weight change before and after the introduction of GLP-1 RA treatment with semaglutide
Pernicious anemia is a condition that happens when the body doesn't make enough red blood cells because the intestine cannot absorb enough vitamin B 12
this treatment will keep skin younger looking, works as a brightening agent, reduces lines and wrinkles, and increases skin elasticity